000 | 01784 a2200505 4500 | ||
---|---|---|---|
005 | 20250516210412.0 | ||
264 | 0 | _c20141021 | |
008 | 201410s 0 0 eng d | ||
022 | _a1745-6215 | ||
024 | 7 |
_a10.1186/1745-6215-15-133 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWestendorp, Willeke F | |
245 | 0 | 0 |
_aUpdate on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial. _h[electronic resource] |
260 |
_bTrials _cApr 2014 |
||
300 |
_a133 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aBacterial Infections _xdiagnosis |
650 | 0 | 4 |
_aCeftriaxone _xadministration & dosage |
650 | 0 | 4 | _aClinical Protocols |
650 | 0 | 4 | _aDisability Evaluation |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aSample Size |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aStroke _xcomplications |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aVermeij, Jan-Dirk | |
700 | 1 | _avan Geloven, Nan | |
700 | 1 | _aDippel, Diederik W J | |
700 | 1 | _aDijkgraaf, Marcel G W | |
700 | 1 | _avan der Poll, Tom | |
700 | 1 | _aPrins, Jan M | |
700 | 1 | _aSpanjaard, Lodewijk | |
700 | 1 | _aVermeij, Frederique H | |
700 | 1 | _aNederkoorn, Paul J | |
700 | 1 | _avan de Beek, Diederik | |
773 | 0 |
_tTrials _gvol. 15 _gp. 133 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1745-6215-15-133 _zAvailable from publisher's website |
999 |
_c23754825 _d23754825 |